Clinical Trial Update: Imaging Study for FdCyd and THU Cancer Treatment [EARLY_Phase 1]

View source ↗

Summary

Early-phase imaging study for FdCyd and THU in cancer was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms
• Head and Neck Neoplasms
• Lung Neoplasms
• Urinary Bladder Neoplasms

Drugs mentioned

• FdCyd (5-fluorodeoxycytidine)
• THU (tetrahydro-uracil)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Head and Neck Neoplasms, Lung Neoplasms | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2020-05-22